Exact Mass: 366.999

Exact Mass Matches: 366.999

Found 71 metabolites which its exact mass value is equals to given mass value 366.999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Anilofos

O,O-Dimethyl ({[(4-chlorophenyl)(propan-2-yl)carbamoyl]methyl}sulphanyl)phosphonothioic acid

C13H19ClNO3PS2 (367.0232)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

Phosalone

O,O-diethyl {[(6-chloro-2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl)methyl]sulfanyl}phosphonothioate

C12H15ClNO4PS2 (366.9869)


CONFIDENCE standard compound; INTERNAL_ID 175; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9787; ORIGINAL_PRECURSOR_SCAN_NO 9783 CONFIDENCE standard compound; INTERNAL_ID 175; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9765; ORIGINAL_PRECURSOR_SCAN_NO 9762 CONFIDENCE standard compound; INTERNAL_ID 175; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9731; ORIGINAL_PRECURSOR_SCAN_NO 9728 CONFIDENCE standard compound; INTERNAL_ID 175; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9703; ORIGINAL_PRECURSOR_SCAN_NO 9702 CONFIDENCE standard compound; INTERNAL_ID 175; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9750; ORIGINAL_PRECURSOR_SCAN_NO 9747 CONFIDENCE standard compound; INTERNAL_ID 175; DATASET 20200303_ENTACT_RP_MIX501; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9781; ORIGINAL_PRECURSOR_SCAN_NO 9778 Phosalone is an organophosphate chemical commonly used as an insecticide and acaricide. It is developed by Rhone-Poulenc in France but EU eliminated it from pesticide registration on December 2006. D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals

   

Cefaclor

(6R,7R)-7-[(2R)-2-amino-2-phenylacetamido]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H14ClN3O4S (367.0394)


Cefaclor is only found in individuals that have used or taken this drug. It is a semisynthetic, broad-spectrum antibiotic derivative of cephalexin. [PubChem]Cefaclor, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins. It is possible that cefaclor interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3069 Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections[1][2][3][4].

   

3-[(2,6-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one

3-[(2,6-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one

C20H11Cl2NO2 (367.0167)


   

3-[(2,4-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one

3-[(2,4-Dichlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one

C20H11Cl2NO2 (367.0167)


   
   

5'-Hydroxymethyl meloxicam

4-hydroxy-N-[5-(hydroxymethyl)-1,3-thiazol-2-yl]-2-methyl-1,1-dioxo-2H-1λ⁶,2-benzothiazine-3-carboximidic acid

C14H13N3O5S2 (367.0297)


5-Hydroxymethyl meloxicam is a metabolite of meloxicam. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and fever reducer effects. It is a derivative of oxicam, closely related to piroxicam, and falls in the enolic acid group of NSAIDs. It was developed by Boehringer-Ingelheim. (Wikipedia)

   

3-(4-Methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole

3-(4-Methanesulphonylphenyl)-4-phenyl-5-(trifluoromethyl)-1,2-oxazole

C17H12F3NO3S (367.049)


   
   

Maybridge3_006658

Maybridge3_006658

C17H12F3NO3S (367.049)


   
   
   
   
   

cefaclor

Cefaclor Impurity C

C15H14ClN3O4S (367.0394)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DC - Second-generation cephalosporins A cephalosporin bearing chloro and (R)-2-amino-2-phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections[1][2][3][4].

   
   
   

Anilofos

Anilofos

C13H19ClNO3PS2 (367.0232)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   
   

CAY10404

3-(4-Methylsulphonylphenyl)-4-phenyl-5-trifluoromethylisoxazole

C17H12F3NO3S (367.049)


   

5-Hydroxy Meloxicam

5-Hydroxy Meloxicam

C14H13N3O5S2 (367.0297)


   

acetic acid,thulium,hydrate

acetic acid,thulium,hydrate

C6H14O7Tm (367.0082)


   

Thiazole, 2,5-dibromo-4-nonyl- (9CI)

Thiazole, 2,5-dibromo-4-nonyl- (9CI)

C12H19Br2NS (366.9605)


   

guanosine 3:5-cyclic monophosphate sodium salt

guanosine 3:5-cyclic monophosphate sodium salt

C10H11N5NaO7P (367.0294)


Cyclic GMP sodium (cGMP) is an important regulator of short-term changes in smooth muscle tone and longer-term responses to chronic drug research or proliferative signals, it is in response to atrial natriuretic peptide (ANP) or nitric oxide (NO). Cyclic GMP sodium interacts with cation channels to regulate ion transport or activate the cyclic GMP-dependent protein kinase to result in protein phosphorylation[1][2]. Cyclic GMP sodium (cGMP) is an important regulator of short-term changes in smooth muscle tone and longer-term responses to chronic drug research or proliferative signals, it is in response to atrial natriuretic peptide (ANP) or nitric oxide (NO). Cyclic GMP sodium interacts with cation channels to regulate ion transport or activate the cyclic GMP-dependent protein kinase to result in protein phosphorylation[1][2]. Cyclic GMP sodium (cGMP) is an important regulator of short-term changes in smooth muscle tone and longer-term responses to chronic drug research or proliferative signals, it is in response to atrial natriuretic peptide (ANP) or nitric oxide (NO). Cyclic GMP sodium interacts with cation channels to regulate ion transport or activate the cyclic GMP-dependent protein kinase to result in protein phosphorylation[1][2].

   

N-[3-(2-bromophenyl)propyl]-4-methylbenzenesulfonamide

N-[3-(2-bromophenyl)propyl]-4-methylbenzenesulfonamide

C16H18BrNO2S (367.0242)


   

3-bromo-5-fluoro-1-tosyl-1H-indole

3-bromo-5-fluoro-1-tosyl-1H-indole

C15H11BrFNO2S (366.9678)


   

Cytidine 5-monophosphate disodium salt

Cytidine 5-monophosphate disodium salt

C9H12N3Na2O8P (367.0157)


   

Sodium feredetate

EDTA FERRIC-SODIUM SALT

C10H12FeN2NaO8 (366.9841)


B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AB - Iron trivalent, oral preparations D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds

   

(ethylenedinitrilo)tetraacetic acid ferric sodium salt dihydrate

(ethylenedinitrilo)tetraacetic acid ferric sodium salt dihydrate

C10H12FeN2NaO8 (366.9841)


   
   

Disperse Yellow 3G

Disperse Yellow 3G

C18H10BrNO3 (366.9844)


   

6,7-Isoquinolinediol,1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydro-, hydrobromide (1:1)

6,7-Isoquinolinediol,1-[(3,4-dihydroxyphenyl)methyl]-1,2,3,4-tetrahydro-, hydrobromide (1:1)

C16H18BrNO4 (367.0419)


   

Copper, bis(nitrato-kO)(1,10-phenanthroline-kN1,kN10)-, (SP-4-2)-

Copper, bis(nitrato-kO)(1,10-phenanthroline-kN1,kN10)-, (SP-4-2)-

C12H8CuN4O6 (366.974)


   

Methyl 2-(benzylamino)-5-iodobenzoate

Methyl 2-(benzylamino)-5-iodobenzoate

C15H14INO2 (367.0069)


   

N-[(7-bromo-1-benzothiophen-3-yl)methyl]-2-chloro-N-ethylethanamine,hydrochloride

N-[(7-bromo-1-benzothiophen-3-yl)methyl]-2-chloro-N-ethylethanamine,hydrochloride

C13H16BrCl2NS (366.9564)


   

3-Bromo-6-fluoro-1-(p-toluenesulfonyl)indole

3-Bromo-6-fluoro-1-(p-toluenesulfonyl)indole

C15H11BrFNO2S (366.9678)


   

2-(4-bromo-3-hydroxy-2-quinolyl)-1H-indene-1,3(2H)-dione

2-(4-bromo-3-hydroxy-2-quinolyl)-1H-indene-1,3(2H)-dione

C18H10BrNO3 (366.9844)


   

Cefadroxil-d4 (major)

Cefadroxil-d4 (major)

C15H14ClN3O4S (367.0394)


   

ETHYLENEDIAMINETETRAACETIC ACID, IRON (III), MONOSODIUM SALT

ETHYLENEDIAMINETETRAACETIC ACID, IRON (III), MONOSODIUM SALT

C10H12FeN2NaO8 (366.9841)


   

Benzenemethanamine, 4-​bromo-​N-​[(4-​bromophenyl)​methyl]​-​N-​methyl-

Benzenemethanamine, 4-​bromo-​N-​[(4-​bromophenyl)​methyl]​-​N-​methyl-

C15H15Br2N (366.9571)


   

4-iodo-N-(oxolan-2-ylmethyl)benzenesulfonamide

4-iodo-N-(oxolan-2-ylmethyl)benzenesulfonamide

C11H14INO3S (366.9739)


   

3-iodo-4-[(4-methylphenyl)methylamino]benzoic acid

3-iodo-4-[(4-methylphenyl)methylamino]benzoic acid

C15H14INO2 (367.0069)


   

3-(4-Methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole

3-(4-Methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole

C17H12F3NO3S (367.049)


CAY10404 is a potent and selective cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 1 nM and a selectivity index (SI; COX-1 IC50/COX-2 IC50) of >500000. CAY10404 is a potent PKB/Akt and MAPK signaling pathways inhibitor and induces apoptosis in non-small cell lung cancer (NSCLC) cells. CAY10404, a diarylisoxazole, has good analgesic, anti-inflammatory, and anti-cancer activities[1][2][3].

   

N-[6-(dimethylsulfamoyl)-1,3-benzothiazol-2-yl]thiophene-2-carboxamide

N-[6-(dimethylsulfamoyl)-1,3-benzothiazol-2-yl]thiophene-2-carboxamide

C14H13N3O3S3 (367.0119)


   

5-bromo-N-[(2-carbamoylanilino)-sulfanylidenemethyl]-2-furancarboxamide

5-bromo-N-[(2-carbamoylanilino)-sulfanylidenemethyl]-2-furancarboxamide

C13H10BrN3O3S (366.9626)


   

5-[1-(Benzenesulfonyl)-3-pyrazolyl]-2-phenylthiazole

5-[1-(Benzenesulfonyl)-3-pyrazolyl]-2-phenylthiazole

C18H13N3O2S2 (367.0449)


   

N-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]-3-(trifluoromethyl)benzamide

N-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]-3-(trifluoromethyl)benzamide

C16H9ClF3N3O2 (367.0335)


   

6-Chloropurine riboside, 5-monophosphate

6-Chloropurine riboside, 5-monophosphate

C10H13ClN4O7P+ (367.021)


   
   

6-hydroxy-7,10-diketo-3-O-methyl-pre-bikaverin

6-hydroxy-7,10-diketo-3-O-methyl-pre-bikaverin

C19H11O8- (367.0454)


   

2-(1,3-benzoxazol-2-ylsulfanyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide

2-(1,3-benzoxazol-2-ylsulfanyl)-N-(4-phenyl-1,3-thiazol-2-yl)acetamide

C18H13N3O2S2 (367.0449)


   

1-[[(5-Bromo-2-furanyl)-oxomethyl]amino]-3-(2,5-dimethylphenyl)thiourea

1-[[(5-Bromo-2-furanyl)-oxomethyl]amino]-3-(2,5-dimethylphenyl)thiourea

C14H14BrN3O2S (366.999)


   

N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-2,2-bis(trifluoromethyl)butanamide

N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-2,2-bis(trifluoromethyl)butanamide

C10H11F6N3OS2 (367.0248)


   

3-bromo-5-ethoxy-N-(4-fluorophenyl)-4-methoxybenzamide

3-bromo-5-ethoxy-N-(4-fluorophenyl)-4-methoxybenzamide

C16H15BrFNO3 (367.0219)


   

[3-(2-Furanyl)-5-(phenylmethylthio)-1,2,4-triazol-1-yl]-thiophen-2-ylmethanone

[3-(2-Furanyl)-5-(phenylmethylthio)-1,2,4-triazol-1-yl]-thiophen-2-ylmethanone

C18H13N3O2S2 (367.0449)


   

N-(5-chloro-2-hydroxyphenyl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide

N-(5-chloro-2-hydroxyphenyl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide

C15H14ClN3O4S (367.0394)


   

4-bromo-N-[(furan-2-carbonylamino)carbamothioyl]benzamide

4-bromo-N-[(furan-2-carbonylamino)carbamothioyl]benzamide

C13H10BrN3O3S (366.9626)


   

2,4-dioxo-1H-pyrimidine-5-carboxylic acid [2-(2-bromoanilino)-2-oxoethyl] ester

2,4-dioxo-1H-pyrimidine-5-carboxylic acid [2-(2-bromoanilino)-2-oxoethyl] ester

C13H10BrN3O5 (366.9804)


   

3-(2-iodophenoxy)-N-methyl-3-phenyl-1-propanamine

3-(2-iodophenoxy)-N-methyl-3-phenyl-1-propanamine

C16H18INO (367.0433)


   

(6R)-7-[(2-amino-1-oxo-2-phenylethyl)amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R)-7-[(2-amino-1-oxo-2-phenylethyl)amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H14ClN3O4S (367.0394)


   

3,6-dihydroxy-2-(3-methoxyphenyl)-7-sulinooxy-3,4-dihydro-2H-chromen-5-olate

3,6-dihydroxy-2-(3-methoxyphenyl)-7-sulinooxy-3,4-dihydro-2H-chromen-5-olate

C16H15O8S- (367.0488)


   

4,5-dihydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide

4,5-dihydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide

C14H13N3O5S2 (367.0297)


   

[(Z)-(3-bromo-2-hydroxy-6,7,8,9-tetrahydrodibenzofuran-1-yl)methylideneamino]thiourea

[(Z)-(3-bromo-2-hydroxy-6,7,8,9-tetrahydrodibenzofuran-1-yl)methylideneamino]thiourea

C14H14BrN3O2S (366.999)


   

[5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

[5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

C12H10N5O7P-2 (367.0318)


   

(3S)-5-bromospiro[1H-indole-3,1-2,3,4,9-tetrahydropyrido[3,4-b]indole]-2-one

(3S)-5-bromospiro[1H-indole-3,1-2,3,4,9-tetrahydropyrido[3,4-b]indole]-2-one

C18H14BrN3O (367.032)


   

phosalone

phosalone

C12H15ClNO4PS2 (366.9869)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D010575 - Pesticides > D007306 - Insecticides D004791 - Enzyme Inhibitors D016573 - Agrochemicals

   

5-Hydroxymethyl meloxicam

5-Hydroxymethyl meloxicam

C14H13N3O5S2 (367.0297)


   

disodium cytidine 5-monophosphate

disodium cytidine 5-monophosphate

C9H12N3Na2O8P (367.0157)


An organic sodium salt that is the disodium salt of CMP.

   

2',3'-cGMP (sodium)

2',3'-cGMP (sodium)

C10H11N5NaO7P (367.0294)


2',3'-cGMP sodium, a cGMP analogue, is an intermediate of RNA catalytic cleavage by binase[1].

   

Sp-cAMPS (sodium salt)

Sp-cAMPS (sodium salt)

C10H11N5NaO5PS (367.0116)


Sp-cAMPS sodium salt, a cAMP analog, is potent activator of cAMP-dependent PKA I and PKA II. Sp-cAMPS sodium salt is also a potent, competitive phosphodiesterase (PDE3A) inhibitor with a Ki of 47.6 μM. Sp-cAMPS sodium salt binds the PDE10 GAF domain with an EC50 of 40 μM[1][2][3].

   

5,6,18,19-tetrahydroxy-9,15-dioxa-12-azapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1(13),2(11),3(8),4,6,16(21),17,19-octaene-10,14-dione

5,6,18,19-tetrahydroxy-9,15-dioxa-12-azapentacyclo[11.8.0.0²,¹¹.0³,⁸.0¹⁶,²¹]henicosa-1(13),2(11),3(8),4,6,16(21),17,19-octaene-10,14-dione

C18H9NO8 (367.0328)